A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2006
10/24/2006	US7125555 Oral preparation containing seaweed for reduction of plaque and calculus
10/24/2006	CA2398963C New salt form and polymorphs
10/24/2006	CA2257121C Methods and compositions for treating urinary incontinence using optically pure (s)-oxybutynin
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109695A1 Composition comprising genetically engineered haptoglobin
10/19/2006	WO2006109671A1 Crystals of morphinan derivative and process for producing the same
10/19/2006	WO2006109635A1 Intestinal absorptive anti-tumor agent
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006108686A2 Bnp agonists
10/19/2006	WO2006108519A1 Therapeutic combination in case of benign prostate hyperplasia
10/19/2006	WO2006064336A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/19/2006	US20060235072 Potassium channel opener
10/19/2006	US20060235057 Phenyl compounds
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060234939 Calcium channel modulator; delayed or sustained release
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234913 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia
10/19/2006	US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006	CA2605224A1 Combination for the therapy of benign prostatic hyperplasia
10/19/2006	CA2602968A1 Crystals of morphinan derivative and process for producing the same
10/18/2006	EP1712237A2 Erythropoietin solution preparation stabilized with leucine, glutamic acid or lysine
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP1107957B1 Pyrimidine compounds
10/18/2006	EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847226A Quinolyl amide derivative and its prepn process and use
10/18/2006	CN1846775A New medicinal use of Chinese medicine nutmeg and its extract
10/18/2006	CN1846772A Uremia treating Chinese medicine
10/18/2006	CN1846765A Kidney benefiting hypoglycemic medicine composition and its prepn process
10/18/2006	CN1846759A Kidney invigorating and heart nourishing Hongfu ointment
10/18/2006	CN1846749A Groundcherry oral liquid and its prepn process
10/18/2006	CN1846747A Chinese medicine for treating prostatic hyperplasia
10/18/2006	CN1846724A Nephropathy treating medicine composition and its prepn process
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846699A Application of 1-(substituted phenyl)-5-methyl-2-(1H)-pyridone compound in preparing medicine for anti-other organifibrosis and tissue fibrosis except renal interstitial fibrosis
10/18/2006	CN1280289C Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1279958C Compound formula preparation eontaining glucocorticoid medicine
10/18/2006	CN1279942C Decoction of Chinese traditional medicine for treating disease of senile acute urine retention
10/18/2006	CN1279938C Chinese patented medicine for treating nephritis
10/18/2006	CN1279915C Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-D)-pyrimidine for treating of urinary incontinence
10/18/2006	CN1279911C Method of treating benign prostatic hyperplasia and other benign prostate conditions
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006	US7122558 Anticholinergic agents; chronic obstructive pulmonary diseases; incontinence; gastrointestinal disorders; antiulcer agents; cardiovascular disorders
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/17/2006	US7122530 24-hydroxyvitamin D, analogs and uses thereof
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122210 A concentrate solution comprising sodium bicarbonate concentrate, electrolyte concentrate; treating renal failure with hemofiltration
10/17/2006	US7122173 A compound having slowly-deactivating A-type K+ channel opening activity such as N-(5,5-dioxido-10-oxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/12/2006	WO2006107708A1 Treatment of disease caused by excess free hemoglobin
10/12/2006	WO2006107059A1 Medicine for renal perfusion disorder
10/12/2006	WO2006106812A1 Propane-1,3-dion derivative or salt thereof
10/12/2006	WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/12/2006	WO2006059304A3 Novel lactame derivatives as renin inhibitors
10/12/2006	WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
10/12/2006	US20060229245 Lyophilized HGF preparations
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	US20060228429 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits
10/12/2006	DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710256A1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006	EP1708990A1 Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity
10/11/2006	EP1708723A1 Method of treating hyperphosphataemia using lanthanum hydroxycarbonate
10/11/2006	EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	EP1363903B1 Indole derivatives and their use as gnrh antagonists
10/11/2006	EP1210374B1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP0814803B1 Use of steroidal estrogen receptor antagonists as male contraceptives
10/11/2006	CN1845927A Microcrystal and medicinal preparation containing the same
10/11/2006	CN1845908A 5-substituted quinazolinone derivatives
10/11/2006	CN1844146A Monoclonal antibody against human B7-1 molecule and its use
10/11/2006	CN1843505A Compound Doxycycline lysozyme enteral capsule
10/11/2006	CN1843500A Medicine for kidney rehabilitation and preparing method thereof
10/11/2006	CN1843473A Method for preparing kidney-nourshing health-preserving liquor containing micron pine pollen, deer antler powder, tortoise plastron powder, curculigo rhizome powder, walnut powder, dried solomonsea
10/11/2006	CN1843472A Method for preparing kidney-nourshing health-preserving boil-free oral liquid containing micron pine pollen, deer antler powder, tortoise plastron powder, curculigo rhizome powder, walnut powder, dr
10/11/2006	CN1843471A Method for preparing kidney-nourshing health-preserving oral liquid containing micron pine pollen, deer antler powder, tortoise plastron powder, curculigo rhizome powder, walnut powder, dried solomo
10/11/2006	CN1843470A Method for preparing kidney-nourshing health-preserving tablet containing micron pine pollen, deer antler powder, tortoise plastron powder, curculigo rhizome powder, walnut powder, dried solomonsea
10/11/2006	CN1843469A Method for preparing kidney-nourshing health-preserving granula and capsule containing micron pine pollen, deer antler powder, tortoise plastron powder, curculigo rhizome powder, walnut powder, dri
10/11/2006	CN1843468A Method for preparing kidney-strengthening fatigue-relieving liquor containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843467A Method for preparing kidney-strengthening fatigue-relieving boil-free oral liquid containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843466A Method for preparing kidney-strengthening fatigue-relieving oral liquid containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843465A Method for preparing kidney-strengthening fatigue-relieving tablet containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843464A Method for preparing kidney-strengthening fatigue-relieving granula, capsule containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843448A Formulation for kidney and its novel preparation method
10/11/2006	CN1843430A Chinese traditional medicine preparation for treating uremia
10/11/2006	CN1843429A Pharmaceutical composition for treating renal failure and its preparation and application

1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 562